Hadeia Mashaqbeh

Dr. Hadeia Mashaqbeh

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 November 2021 in Polymers
Verified
Journal Article
Open access
PDF file
HMHadeia Mashaqbeh
Hadeia Mashaqbeh
RORana Obaidat
Rana Obaidat
NANizar Al-Shar'i
Nizar Al-Shar'i
Cyclodextrin polymers and cyclodextrin-based nanosponges have been widely investigated for increasing drug bioavailability. This study examined curcumin’s complexation stability and solubilization with β-cyclodextrin and β-cyclodextrin-based nanosponge. Nanosponges were prepared through the cross-linking of β-cyclodextrin with different molar ratios of diphenyl carbonate. Phase solubility experiments were conducted to evaluate the formed complexes and evaluate the potential of using β-cyclodextrin and nanosponge in pharmaceutical formulations. Furthermore, physicochemical characterizations of the prepared complexes included PXRD, FTIR, NMR, and DSC. In addition, in vitro release studies were performed for the prepared formulations. The formation of β-cyclodextrin complexes enhanced curcumin solubility up to 2.34-fold compared to the inherent solubility, compared to a 2.95-fold increment in curcumin solubility when loaded in β-cyclodextrin-based nanosponges. Interestingly, the stability constant for curcumin nanosponges was (4972.90 M−1), which was ten times higher than that for the β-cyclodextrin complex, where the value was 487.34 M−1. The study results indicated a decrease in the complexation efficiency and solubilization effect with the increased cross-linker amount. This study’s findings showed the potential of using cyclodextrin-based nanosponge and the importance of studying the effect of cross-linking density for the preparation of β-cyclodextrin-based nanosponges to be used for pharmaceutical formulations.

21 March 2025 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
MRMeriem Rezigue
Meriem Rezigue
HMHadeia Mashaqbeh
Hadeia Mashaqbeh
Alaa A. A. AljabaliAlaa A. A. Aljabali
Alaa A. A. Aljabali
RMRanda Mansour
Randa Mansour
IHIyad Deeb Hamzeh
Iyad Deeb Hamzeh
Background/Objectives: The topical delivery of antibiotics through transethosomes shows promise for enhancing its dermal delivery for the treatment of skin infections. This study aimed to develop and characterize azithromycin-loaded transethosomes to enhance topical drug delivery and improve the antibacterial activity of azithromycin. Methods: The prepared azithromycin formulations underwent assessment for various characteristics, including their vesicle dimensions, size distribution, zeta potential, encapsulation efficiency, and morphological features (via TEM analysis). Additionally, their thermal properties were examined through DSC analysis, and their stability was monitored over six months under refrigerated storage conditions. The sequential tape-stripping technique was employed to conduct ex vivo penetration studies on human skin. Interactions between transethosomes and stratum corneum lipids were examined using attenuated total reflectance Fourier-transform infrared spectroscopy (ATR-FTIR). Additionally, the formulations were tested for their in vitro antibacterial efficacy against Staphylococcus aureus. Results: The findings revealed that AZ 1 and AZ 2 had vesicle sizes of 108.44 ± 5.72 nm and 70.42 ± 6.02 nm, zeta potential measurements of −11.897 ± 1.820 mV and −34.575 ± 4.535 mV, and high entrapment efficiencies of 99.259 ± 0.086% and 99.560 ± 0.014%, respectively. Transmission electron microscopy (TEM) analysis confirmed the spherical nature of the vesicles, whereas differential scanning calorimetry (DSC) confirmed the successful encapsulation of azithromycin in transethosomes. The formulations exhibited acceptable physical stability at 4 °C for six months. Ex vivo studies revealed a significantly higher deposition of azithromycin in the skin by both transethosome formulations than by the drug solution (p < 0.05), with low systemic absorption. Among the formulations, AZ 2 resulted in much deeper skin penetration, with deeper dermal and epidermal layer deposition (1.388 ± 0.242 µg/cm2) compared to AZ 1 (four-fold higher, p < 0.05) and to the control drug solution (12 times more, p < 0.05). Analysis using ATR-FTIR suggested that azithromycin-loaded transethosomes improve the drug penetration by increasing the lipid fluidity and extracting lipids from the stratum corneum. Moreover, the transethosomes loaded with azithromycin demonstrated enhanced antibacterial efficacy against Staphylococcus aureus, with minimum inhibitory concentration (MIC) values that were lower than those of the free drug solution. Conclusion: The results highlight the promising potential of transethosomes as a novel topical drug delivery system for azithromycin that offers improved therapeutic effects against skin infections

27 May 2024 in Advances in Pharmacological and Pharmaceutical Sciences
Verified
Journal Article
Open access
PDF file
HMHadeia Mashaqbeh
Hadeia Mashaqbeh
BABatool Al-Ghzawi
Batool Al-Ghzawi
FBFatima BaniAmer
Fatima BaniAmer
The characteristics of injectable hydrogels make them a prime contender for various biomedical applications. Hyaluronic acid is an essential component of the matrix surrounding the cells; moreover, hyaluronic acid’s structural and biochemical characteristics entice researchers to develop injectable hydrogels for various applications. However, due to its poor mechanical properties, several strategies are used to produce injectable hyaluronic acid hydrogel. This review summarizes published studies on the production of injectable hydrogels based on hyaluronic acid polysaccharide polymers and the biomedical field’s applications for these hydrogel systems. Hyaluronic acid-based hydrogels are divided into two categories based on their injectability mechanisms: in situ-forming​ injectable hydrogels and shear-thinning injectable hydrogels. Many crosslinking methods are used to create injectable hydrogels; chemical crosslinking techniques are the most frequently investigated technique. Hybrid injectable hydrogel systems are widely investigated by blending hyaluronic acid with other polymers or nanoparticulate systems. Injectable hyaluronic acid hydrogels were thoroughly investigated and proven to demonstrate potential in various medical fields, including delivering drugs and cells, tissue repair, and wound dressings.

14 July 2024 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Closed access
HMHadeia Mashaqbeh
Hadeia Mashaqbeh
RORana Obaidat
Rana Obaidat
MAMo'TAsem M. Alsmadi
Mo'TAsem M. Alsmadi
SBSanaa Bardaweel
Sanaa Bardaweel
NHNabil Hailat
Nabil Hailat

17 October 2025 in Gels
Verified
Journal Article
Open access
PDF file
HMHadeia Mashaqbeh
Hadeia Mashaqbeh
RHRania Hamed
Rania Hamed
HAHiba Alzoubi
Hiba Alzoubi
RORana Obaidat
Rana Obaidat
MAMohammad Alnaief
Mohammad Alnaief
MOMohammad Obeid
Mohammad Obeid
This study reports the use of an in situ-forming gel based on hyaluronic–chitosan–glycerophosphate for wound healing. Hydrogels with optimized thermoresponsive gelling, rheological, and prolonged drug release properties were developed and incorporated with ciprofloxacin and carvacrol. In vitro evaluations included rheological studies, swelling degree, degradation rates, morphological analysis, antioxidant effects, antimicrobial activity, and drug release studies. The effectiveness of the optimized hydrogel was assessed using an animal ischemic wound rabbit ear model. The incorporation of ciprofloxacin and carvacrol into the combined hydrogel system maintained the mechanical strength of the formula, with a G′/G″ ≈ ratio of approximately 15.6, interconnected porosity, and controlled swelling. It enhanced antimicrobial activity against both S. aureus and E. coli. In addition, the developed gel exhibited sustained release following the Higuchi diffusion kinetics. The quantitative wound area% indicated that on day 9, the mean wound area decreased from 81.8% for the control to 51.2% for the developed gel. The study findings demonstrate the suitability and potential of this system as multifunctional wound-healing formulations that promote moist healing, antimicrobial and antioxidant activities, while providing sustained therapeutic delivery over 24 h.

26 September 2025 in Gels
Verified
Journal Article
Open access
PDF file
MAMohammad Alnaief
Mohammad Alnaief
BMBalsam Mohammad
Balsam Mohammad
IAIbrahem AlTarawneh
Ibrahem AlTarawneh
DADema Alkhatib
Dema Alkhatib
ZAZayed Al-Hamamre
Zayed Al-Hamamre
RORana Obeidat
Rana Obeidat
Hybrid polysaccharide-based aerogels offer significant potential as advanced drug delivery platforms due to their tunable structure, high porosity, and biocompatibility. In this study, aerogel microparticles were synthesized using alginate, pectin, carrageenan, and their hybrid formulations via an emulsion–gelation technique followed by supercritical fluid CO2 extraction. The resulting aerogels exhibit mesoporous structures with specific surface areas ranging from 324 to 521 m2/g and pore volumes between 1.99 and 3.75 cm3/g. Comprehensive characterization (SEM, gas sorption, XRD, TGA, DSC, and FTIR) confirmed that hybridization improved morphological uniformity and thermal stability compared to single polymer aerogels. Ibuprofen was used as a model drug to evaluate loading efficiency and release kinetics. Among all formulations, the alginate/carrageenan (2:1) hybrid showed the highest drug loading efficiency (93.5%) and a rapid release profile (>90% within 15 min), closely matching the performance of commercial ibuprofen tablets. Drug release followed Fickian diffusion, as confirmed by the Korsmeyer–Peppas model (R2 > 0.99). These results highlight the potential of hybrid polysaccharide aerogels as vehicles for drug delivery and other fast-acting therapeutic applications.